Dr. Shahram Hormozi, MD

Dr. Hormozi practices at South Shore University Hospital in Bay Shore, New York, part of Northwell Health.

Dr. Hormozi's NPI, 1215916721, was assigned on January 12, 2006. Dr. Hormozi graduated from State University of New York at Stony Brook, School of Medicine in 1994. Dr. Hormozi holds New York license 201817.

Dr. Hormozi's primary practice is South Shore University Hospital, at 301 East Main Street, Bay Shore, NY 11706 in Suffolk County. The practice phone is (631) 968-3000.

Dr. Hormozi's primary practice is South Shore University Hospital in Bay Shore, New York, part of Northwell Health. Dr. Hormozi is also affiliated with North Shore University Hospital. The medical group on file is Northwell Health Physician Partners Cardiology at Great Neck. Dmand AI also links Dr. Hormozi to 4 more hospitals, 4 medical groups, 3 group practices and clinics, 1 physician office and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hormozi practices, 11 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Hormozi's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Hormozi is licensed in New York.

CMS data shows 15,502 Medicare services from Dr. Hormozi across 31 procedure codes in 2024, for 3,015 Medicare patients. Medicare paid $892,149 for them.

CMS counts 3,015 Medicare patients who saw Dr. Hormozi in 2024. The largest group is 75 to 84, with 1,097 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 1.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hormozi's median patient age at 65, with 48% women.

In 2024, Dr. Hormozi wrote 6,627 Medicare Part D claims for 768 patients. 89% of them were for generic drugs. CMS names the drug for 6,326 of them, across 57 drugs with 11 or more claims each, at $1,000,001 in total drug cost. In 2023, CMS named 5,769 claims across 53 drugs.

Dr. Hormozi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 104 procedures of coronary angioplasty and stenting by Dr. Hormozi, more than 97% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 1,265 general payments to Dr. Hormozi from 61 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 58% of the total. Novartis Pharmaceuticals Corporation paid the most, $16,955.

Dr. Hormozi graduated from State University of New York at Stony Brook, School of Medicine in 1994.